Richard Nieman
2022
In 2022, Richard Nieman earned a total compensation of $1.4M as Chief Medical Officer at Lyra Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $1,024,301 |
| Salary | $205,625 |
| Other | $19,541 |
| Total | $1,399,467 |
Nieman received $1M in option awards, accounting for 73% of the total pay in 2022.
Nieman also received $150K in non-equity incentive plan, $205.6K in salary and $19.5K in other compensation.
Rankings
In 2022, Richard Nieman's compensation ranked 2,376th out of 5,760 executives tracked by ExecPay. In other words, Nieman earned more than 58.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,376 out of 5,760 | 59th |
Division Manufacturing | 1,302 out of 3,136 | 59th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 155 out of 485 | 68th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 102 out of 347 | 71st |
Industry Surgical and Medical Instruments and Apparatus | 85 out of 253 | 66th |
Source: SEC filing on April 25, 2023.
Nieman's colleagues
We found two more compensation records of executives who worked with Richard Nieman at Lyra Therapeutics in 2022.